Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

HIV-STD 2019

About Conference


About the Conference:

Conference Series LLC Ltd is beaming to invite all the experts in the field of Infectious Diseases, Immunology, Virology, for the forthcoming event “9th Global Experts Conference on HIV/AIDS, STDs and Co-Infections” which is going to be held on November 06-07, 2019 at Yokohama, Japan.

This Conference focus on HIV Science features the latest HIV science, including basic, clinical and prevention research. It brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. As HIV/AIDS is an alarming concern throughout the world, HIV-STD 2019 will mainly focus on issues like primary HIV Infection, Transmission and eradication issues apart from this HIV Co-infection, HIV Current pharmaceutical design would cover the experimental drugs developed.

HIV-STD 2019, lays perfect platform for physicians, nurses/nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Academicians and professionals working in the field of HIV medicine.

Who should attend?

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from

Target Audience:

  • Physicians in the field of Vaccine and research
  • Vaccine &Immunology Associations and Societies
  • Training Institutes
  • Physicians and nurses with a special emphasis on infectious diseases
  • Public health professionals
  • Community health educators
  • Members of academia
  • Health professionals
  • Nurse Practitioners
  • Pharmacists
  • Social Workers
  • Academia
  • Students
  • Researchers
  • STD-AIDS associations and societies
  • Vaccines & Immunization, Scientists

Sessions/Tracks

Conference Highlights:

  • HIV/AIDS
  • HIV/AIDS Signs and Symptoms:
  • HIV and Cancer: Risks, Types, and Treatment
  • HIV/Viral Hepatitis
  • HIV Drug Discovery and Research
  • HIV and AIDS Nursing Care Management
  • HIV Diagnosis
  • AIDS Stigma and Discrimination
  • Preventing Mother-to-Child Transmission of HIV
  • Sexually transmitted diseases (STDs)
  • Infectious Diseases Prevention, Control and Cure
  • Viral Infectious Diseases
  • Vaccine Development for STDS
  • Public Awareness on STDS
  • Pediatric HIV Treatment Initiative

 

Track 1: HIV/AIDS

HIV stands for human immunodeficiency virus, which causes HIV infection. HIV attacks and destroys the CD4 cells of the immune system (CD4 is a glycoprotein found on the surface of immune cells such as T helper cells, monocytes, dendritic cells, and macrophages). In initial stage of infection, person may not notice any symptoms or experience a brief period of influenza-like illness. As the infection progresses, it interferes more with the immune system, makes it harder and harder for the body to fight off infections and some other diseases. Opportunistic infections or cancers take advantage of a very weak immune system and signal that the person has AIDS. The loss of CD4 cells makes it difficult for the body to fight infections and certain cancers. HIV can gradually destroy the immune system and advance to AIDS if it is not treated with drugs.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA), European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS Society, Association for Professionals in Infection Control and Epidemiology, Infectious Diseases Society of America (IDSA), HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 2: HIV/AIDS Signs and Symptoms

The symptoms of HIV vary, depending on the individual and the stage of the disease is: Early stage, Clinical latency stage and AIDS. The first signs of Hiv generally appear within 2-4 weeks after HIV infection. Primary infection (Acute HIV) develop a flu-like illness within a month or two after the virus enters the body. signs and symptoms are: Fever, Headache, Muscle aches and joint pain, Rash, Sore throat and painful mouth sores, Swollen lymph glands, mainly on the neck. Clinical latent infection (Chronic HIV) During this stage, HIV is still active but reproduces at very low levels. People with chronic HIV infection may not have any HIV-related symptoms, or only mild ones. In some individuals, persistent swelling of lymph nodes occurs during this stage. This stage lasts around 10 years.  When AIDS occurs, your immune system will be severely damaged. You'll be more likely to develop opportunistic infections. soaking night sweats, Recurring fever, Chronic diarrhea, Weight loss, Persistent white spots / unusual lesions on tongue or in  mouth, Persistent, Skin rashes, unexplained fatigue or bumps.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 3: HIV and Cancer:  Risks, Types, and Treatment

 HIV infected People have extensively higher risk of some types of cancer compared with uninfected people. some of these cancers can develop and grow more quickly because of a weakened immune system  . People with HIV infection or AIDS are more likely to have certain other risk factors for cancer, such as being smokers, heavy alcohol use, needle sharing. certain types of cancer are more common in people with HIV than in people without it, these  types of cancers known as “AIDS-defining cancers”. These cancers include Kaposi sarcoma, Non-Hodgkin lymphoma, cervical cancer, Anal cancer, Oral and oropharyngeal cancer, Lung cancer. Standard treatments for cancer include. chemotherapy, radiation, immunotherapy, targeted therapy, surgery.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 4: HIV/Viral Hepatitis

Human Immunodeficiency Virus (HIV) and Hepatitis B virus (HBV) are bloodborne viruses transmitted primarily through sexual contact and injection drug use. Because of these same modes of transmission, people at risk for HIV infection are also at risk for HBV infection. HIV infected people are disproportionately affected by viral hepatitis, and those who are coinfected are at increased risk for serious, life-threatening complications. Viral hepatitis infection is often serious in people living with HIV and may lead to liver damage more rapidly, persons at risk for HIV be tested for HBV and HCV infection  and vaccinated against hepatitis B and hepatitis C.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 5: HIV Drug Discovery and Research

The most advanced HIV treatments seeks to inhibit the virus’ ability to replicate its RNA and produce more copies of itself.  HIV protease (an enzyme that cleaves and processes viral precursor proteins letting virion maturation). Treatment regimens containing combinations of reverse transcriptase and protease inhibitors, very often known as Highly Active Antiretroviral Therapy (HAART), it revolutionized the treatment of people with HIV by markedly reducing viral load and decreasing the incidence of AIDS-associated opportunistic infections. Many patients receiving HAART nevertheless experience metabolic abnormalities and drug toxicities, have difficulty adhering to the complex drug regimens, and grow strains of HIV resistant to therapy.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)


Track 6: HIV and AIDS Nursing Care Management

People with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and chronic depression constitute a growing population of individuals in need of quality nursing care management. Nursing Care of Patients with HIV/AIDS facilities ranging from the primary-level health center to the tertiary-level hospital who work in a variety of roles to provide care to those with HIV. Nurses provide life-saving and life-enriching care patients with HIV.  Inpatient persons with HIV requires intensive nursing care. HIV disease may cause psychosocial transition (person's experience, view changes on the world), a stress-inducing experience, a developmental experience, , and existential crisis.   Nurses with resource-limited areas with evidence-based knowledge they can deliver safe and effective care to the patients.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 7: HIV Diagnosis and  Health Monitoring

Several types of tests check your blood or body fluids to see if you're infected.  These tests look for antibodies to the virus that the body creates to fight the virus. HIV is most commonly diagnosed by testing your blood or saliva for antibodies to the virus. Unfortunately, it takes time for your body to develop these antibodies —usually up to 12 weeks. If your sexual history and current signs and symptoms suggest that you have an STI, laboratory tests can identify the cause and detect coinfections you might have contracted. Blood tests can confirm the diagnosis of HIV or later stages of syphilis.  Some STIs can be confirmed with a urine sample. If you have active genital sores, testing fluid and samples from the sores may be done to diagnose the type of infection.

  • ELISA Test
  • Western Blot
  • Saliva Tests
  • Viral Load Test
  • Home Tests         

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)                                                                                                                                               

Track 8: AIDS Stigma and Discrimination

HIV-related stigma and discrimination refers to prejudice, negative attitudes and abuse directed at people living with HIV and AIDS. Stigma and discrimination also make people vulnerable to HIV. Those most at risk to HIV continue to face stigma and discrimination based on their actual or perceived health status, race, socioeconomic status, age, sex, sexual orientation or gender identity or other grounds. HIV/AIDS discrimination exists around the world, including ostracism, rejection, discrimination, and avoidance. Consequences of stigma and discrimination may result in low turn-out for HIV counselling and testing, identity crises, isolation, loneliness, low self-esteem and lack of interest in containing the disease

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 9: Preventing Mother-to-Child Transmission of HIV

Mother-to-child transmission of HIV is the spread of HIV from a woman with HIV to her child during pregnancy, childbirth (also called labor and delivery), or breastfeeding (through breast milk). Mother-to-child transmission of HIV is also called perinatal transmission of HIV.  prevention mother to child transmission of HIV (PMTCT), provide a range of services to women and infants. These include preventing HIV infections among women of reproductive age preventing unwanted pregnancies among women living with HIV, and providing women living with HIV with lifelong ART to maintain their health and prevent transmission during pregnancy, labor and breastfeeding. PMTCT programmes also support safe childbirth practices and appropriate infant feeding, as well as providing infants exposed to HIV with virological testing after birth and during the breastfeeding period, ART for prevention and effective treatment.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 10: Sexually transmitted diseases (STDs)

Sexually transmitted diseases (STDs), or sexually transmitted infections (STIs), are generally acquired by sexual contact. Some STDs can spread through the use of unsterilized drug needles, from mother to infant during childbirth or breast-feeding, and blood transfusions. STDs are common and it is possible to be infected without being aware because many STDs do not display obvious signs or symptoms. STD testing once or twice every year is recommended. The most common STD's are:

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 11: Infectious Diseases Prevention, Control and Cure

 Infection Prevention and Control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Antibiotics and Antivirals plays an important role in the prevention and treatment of infectious diseases. Antibiotics are strong medicines that fights against the bacterial infection by stopping them to reproduce or kill bacteria. Infections can be cured by various antibiotics and antimicrobials.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 12: Viral Infectious Diseases

 Viruses are the smallest parasites, typically ranging from 0.02 to 0.3μm, although several very large viruses up to 1μm long. Viruses depend completely on cells (bacterial, plant, or animal) to reproduce. Viruses have an outer cover of protein and sometimes lipid. Viruses are classified principally according to the nature and structure of their genome and their method of replication, not according to the diseases they cause. Diseases caused by viruses are AIDS, Zika virus, human immunodeficiency virus (HIV), hepatitis C, polio, influenza, Dengue fever, H1N1 swine flu, Ebola, Herpes simplex, Measles, Poliomyelitis, Rabies, Rotavirus, Rubella, Influenza.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 13: Vaccine Development for STDs

One important prevention tool against sexually transmitted diseases and infections (STDs/STIs) is vaccination. Currently, vaccines are available to protect against infection with HPV, hepatitis A and hepatitis B. Other vaccines are under development, including those for HIV and herpes simplex virus (HSV). The development of safe and effective STD vaccines offers a potent tool for the control of STDs, including direct and indirect prevention of HIV infection.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 14: Public Awareness on STDs

Educational and awareness programs must be conducted to improve the public knowledge about the sexually transmitted diseases. People affected by sexually transmitted diseases have dramatically increased, millions of people are affected by the disease due to lack of awareness. Public must be aware about the impact of STDs on the lives of the affected people and the importance of preventing, screening and treating STDs. Poor knowledge about the STDs lead to increased health issues such as ectopic pregnancies, infertility and other complications. 

  •  Health care workers should promote early use of services for people with symptoms or concerns about STIs/RTIs.
  •  Raising awareness of STIs/RTIs and their complications.
  •  Educating people about STI/RTI 

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 15: Pediatric HIV Treatment Initiative

Pediatric HIV Treatment Initiative (PHTI) to spur innovation and access to improve the lives of children living with HIV. PHTI will focus on overcoming the barriers to developing and delivering specific pediatric formulations and combinations appropriate for children.

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

Track 16:  HIV Transmission and prevention

HIV  transmit only through specific activities. Most commonly, people get or transmit HIV through sexual behaviors and needle or syringe use. Only certain body fluids—blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids, and breast milk—from a person who has HIV can transmit HIV. These fluids must come in contact with a mucous membrane or damaged tissue or be directly injected into the bloodstream (from a needle or syringe) for transmission to occur.

  • Undetectable viral load and treatment as prevention
  • The biology of HIV transmission
  • Sexual transmission
  • Medical procedures and other blood-borne exposure
  • Condoms and lubricant
  • Behavior change interventions
  • HIV prevention vaccine
  • Epidemiology and behavior
  • HIV prevention policy

Related conferences:

HIV Conference 2019 | STD Conference 2019 | HIV/AIDS Conference 2019 |

7th International Conference on HIV/AIDS, STDs and STIs ,March 18-19, 2019 New York, USA; 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain; 8th EuroScicon Conference on Infectious Diseases & STD-AIDS, April 22-23, 2019, Athens, Greece; HIV, STD & STIS December 06-07,2019  Dubai, UAE; International Conference On HIV-AIDS, STD's & STI's, June 03 - 04, 2019 London, UK;   The STD AIDS Council, Dec 06-07, 2019, Singapore; 5th International Conference on Sexually Transmitted Diseases,  July 17-18, 2019,London, UK; 9th Asia Pacific STD and Infectious Diseases Congress, October 21-22, 2019, Tokyo, Japan; 2nd World Congress on HIV AIDS STD and STI during September 09-10, 2019 at Bangkok, Thailand; The STD/AIDS Council during Dec 06-07, 2019 at Singapore;

Associations and Societies:

Japan AIDS & Society Association (JASA)European AIDS Clinical Society, British HIV AssociationHIV Medicine Association, International AIDS SocietyAssociation for Professionals in Infection Control and EpidemiologyInfectious Diseases Society of America (IDSA)HIV Medicine Association, International Society For STD Research (ISSTDR)

 

Market Analaysis

Past Conference Report

STD-HIV AIDS 2018

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 06-07, 2019

Speaker Opportunity

Supported By

Journal of AIDS & Clinical Research Journal of HIV & Retro Virus Journal of Primary & Acquired Immunodeficiency Research Journal of Antivirals & Antiretrovirals

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos